Agnieszka Maciej-Olejarz
Medyczna 9, PL 30-688
Krakow, MA 30688, Poland
Krakow, MA 30688, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Virtual Screening, Synthesis and In Vitro Characterization of Histamine H4 Receptor Ligands Based on Pyrimidine Scaffolds.
Journal: International journal of molecular sciences
Published: May 24, 2026
D2AAK1 derivatives as neuroprotective agents: Synthesis and structural and pharmacological evaluation.
Journal: Bioorganic chemistry
Published: January 21, 2026
Rational Design, Synthesis and Pharmacological Evaluation of Chalcones as Dual-Acting Compounds-Histamine H3 Receptor Ligands and MAO-B Inhibitors.
Journal: International journal of molecular sciences
Published: December 05, 2025
Synthesis, Experimental and Computational Evaluation of SERAAK1 as a 5-HT2A Receptor Ligand.
Journal: Molecules (Basel, Switzerland)
Published: March 26, 2025
Guanidine Derivative ADS1017, a Potent Histamine H3 Receptor Antagonist with Promising Analgesic Activity and Satisfactory Safety Profile.
Journal: ACS chemical neuroscience
Published: December 09, 2024
The psychoplastogens ibogaminalog and ibogainalog induce antidepressant-like activity in naïve and depressed mice by mechanisms involving 5-HT2A receptor activation and serotonergic transmission.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: September 18, 2024
First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer's Disease.
Journal: Journal of medicinal chemistry
Published: January 08, 2024
Superiority of the Triple-Acting 5-HT6R/5-HT3R Antagonist and MAO-B Reversible Inhibitor PZ-1922 over 5-HT6R Antagonist Intepirdine in Alleviation of Cognitive Deficits in Rats.
Journal: Journal of medicinal chemistry
Published: October 05, 2023
Anti-Inflammatory Activities of 8-Benzylaminoxanthines Showing High Adenosine A2A and Dual A1/A2A Receptor Affinity.
Journal: International journal of molecular sciences
Published: July 27, 2023
Hydrophobicity modulation via the substituents at positions 2 and 4 of 1,3,5-triazine to enhance therapeutic ability against Alzheimer's disease for potent serotonin 5-HT6R agents.
Journal: European journal of medicinal chemistry
Published: April 01, 2023
Trisubstituted 1,3,5-Triazines as Histamine H4 Receptor Antagonists with Promising Activity In Vivo.
Trisubstituted 1,3,5-Triazines as Histamine H4 Receptor Antagonists with Promising Activity In Vivo.
Journal: Molecules (Basel, Switzerland)
Published: March 30, 2023
Last Updated: 09/26/2026